English | 简体中文 | 繁體中文 | 한국어 | 日本語
Tuesday, 1 December 2020, 04:40 HKT/SGT
Share:
    

Source: China Shineway Pharmaceutical Group Limited
China Shineway Pharmaceutical records 29.4% revenue growth in October

HONG KONG, Dec 1, 2020 - (ACN Newswire) - China Shineway Pharmaceutical (stock code: 2877.HK) recorded 29.4% revenue growth for October 2020 in comparison with the same period last year, as sales of injection products, soft capsule products, granule products, TCM formula granules, and other dosage forms went up 38.9%, 17.4%, 38.1%, 7.9% and 54.0% respectively.

Topic: Press release summary
Source: China Shineway Pharmaceutical Group Limited

Sectors: Healthcare & Pharm
https://www.acnnewswire.com
From the Asia Corporate News Network


Copyright © 2024 ACN Newswire. All rights reserved. A division of Asia Corporate News Network.

 

China Shineway Pharmaceutical Group Limited Related News
May 13, 2021 22:04 HKT/SGT
President Xi Jinping reiterates the country's support for Traditional Chinese Medicine
May 13, 2021 21:55 HKT/SGT
Shineway (2877.HK) Q1 revenue increased by 37.0%
Nov 30, 2020 14:00 HKT/SGT
Shineway Pharmaceutical (2877.HK) recorded 29.4% revenue growth for October 2020
Nov 30, 2020 14:00 HKT/SGT
神威藥業 (02877.HK) 十月份單月營業額比去年同期錄得29.4%增長
Nov 30, 2020 14:00 HKT/SGT
神威药业 (02877.HK) 十月份单月营业额比去年同期录得29.4%增长
More news >>
Copyright © 2024 ACN Newswire - Asia Corporate News Network
Home | About us | Services | Partners | Events | Login | Contact us | Cookies Policy | Privacy Policy | Disclaimer | Terms of Use | RSS
US: +1 214 890 4418 | China: +86 181 2376 3721 | Hong Kong: +852 8192 4922 | Singapore: +65 6549 7068 | Tokyo: +81 3 6859 8575